Hyperprolactinemia; etiology, diagnosis and treatment alternatives.
Conner
P
P
Department of Woman and Child Health, Karolinska Hospital, Stockholm, Sweden.
Fried
G
G
D000634:Aminoquinolines / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010479:Pergolide / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood / Q000187:drug effects / Q000378:metabolism*; D011981:Receptors, Prolactin / Q000378:metabolism*
D000634:Aminoquinolines; D018491:Dopamine Agonists; D004873:Ergolines; D011981:Receptors, Prolactin; D010479:Pergolide; D001971:Bromocriptine; C046650:quinagolide; D011388:Prolactin; D000077465:Cabergoline